Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: IMMUNEONCO-B(01541) the Revenue is 9.655 M (-59.92%);the EBIT is -93.05 M (-12.39%);the EPS is -0.219 (-6.96%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.01B59.92%
----
----
EBIT
-0.09B12.39%
----
----
EPS
-0.21936.96%
----
----
Revenue
ActualEstimateUnit: HKD
qf
EBIT
ActualEstimateUnit: HKD
qf
Net income
ActualEstimateUnit: HKD
qf
EPS
ActualEstimateUnit: HKD
qf